Payden & Rygel Investment Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$6.4M Sell
43,800
-47,100
-52% -$7M 0.52% 67
2024
Q1
$14.4M Buy
+90,900
New +$14.5M 0.68% 60
2023
Q3
$12.2M Buy
+78,300
New +$12.9M 0.83% 56

Other funds holding JNJ

Payden & Rygel Investment Group's JNJ Position: Q2 2024 in Review

Payden & Rygel Investment Group reduced its Johnson & Johnson (JNJ) stake by 52% in Q2 2024, selling an estimated $7M and leaving 43,800 shares worth $6.4M. The position accounts for 0.52% of the portfolio, ranked #67.

Payden & Rygel Investment Group first reported a position in JNJ in Q3 2023 and has held it in 3 quarters since. The position peaked at $14.4M in Q1 2024. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Payden & Rygel Investment Group held 43,800 shares of Johnson & Johnson worth $6.4M as of Q2 2024.
  • Payden & Rygel Investment Group sold 47,100 Johnson & Johnson shares in Q2 2024, an estimated $7M.
  • Johnson & Johnson made up 0.52% of Payden & Rygel Investment Group's portfolio in Q2 2024, its #67 holding.
  • Payden & Rygel Investment Group first reported a position in Johnson & Johnson in Q3 2023 and has held it in 3 quarters since.
  • Payden & Rygel Investment Group's Johnson & Johnson position peaked at $14.4M in Q1 2024.
  • 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.